Adiponectin and its receptors: Implications for obesity-associated diseases and longevity

The Lancet Diabetes and Endocrinology

Volumn 2, Issue 1, 2014, Pages 8-9

  Kadowaki, Takashi ^a   Yamauchi, Toshimasa ^a   Okada Iwabu, Miki ^a   Iwabu, Masato ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ADIPONECTIN RECEPTOR 1; ADIPONECTIN RECEPTOR 2; CERAMIDASE; FIBROBLAST GROWTH FACTOR 21; ADIPONECTIN RECEPTOR;

ATHEROSCLEROSIS; DISEASE ASSOCIATION; DRUG TARGETING; ENZYME ACTIVATION; FATTY LIVER; HUMAN; LETTER; LONGEVITY; MALIGNANT NEOPLASTIC DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; COMPLICATION; DOWN REGULATION; GENETICS; METABOLISM; PHYSIOLOGY;

ADIPONECTIN; DOWN-REGULATION; HUMANS; OBESITY; RECEPTORS, ADIPONECTIN;

EID: 84890182018     PISSN: 22138587     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2213-8587(13)70120-7     Document Type: Letter

References (10)

1. Matsuzawa Y Therapy insight: adipocytokines in metabolic syndrome and related cardiovascular disease. Nat Clin Pract Cardiovasc Med 2006, 3:35-42.
2. Yamauchi T, Kamon J, Waki H, et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001, 7:941-946.
3. Kadowaki T Insights into insulin resistance and type 2 diabetes from knockout mouse models. J Clin Invest 2000, 106:459-465.
4. Yamauchi T, Kadowaki T Adiponectin receptor as a key player in healthy longevity and obesity-related diseases. Cell Metab 2013, 17:185-196.
5. 2+ and AMPK/SIRT1. Nature 2010, 464:1313-1319.
6. Holland WL, Miller RA, Wang ZV, et al. Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin. Nat Med 2011, 17:55-63.
7. Okada-Iwabu M, Yamauchi T, Iwabu M, et al. A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity. Nature 2013, published online Oct 30. 10.1038/nature12656.
8. Atzmon G, Pollin TI, Crandall J, et al. Adiponectin levels and genotype: a potential regulator of life span in humans. J Gerontol A Biol Sci Med Sci 2008, 63:447-453.
9. Esposito K, Pontillo A, Di Palo C, et al. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA 2003, 289:1799-1804.
10. Holland WL, Adams AC, Brozinick JT, et al. An FGF21-adiponectin-ceramide axis controls energy expenditure and insulin action in mice. Cell Metab 2013, 17:790-797.